Evaluation of tulathromycin for the treatment of pneumonia following experimental infection of swine with Mycoplasma hyopneumoniae. 2005

Jo McKelvie, and Jeremy H Morgan, and Ian A Nanjiani, and John Sherington, and Tim G Rowan, and Simon J Sunderland
Veterinary Medicine Research and Development, Pfizer Ltd, Sandwich, Kent, UK.

Tulathromycin was evaluated in the treatment of pneumonia in weaned pigs inoculated intranasally with Mycoplasma hyopneumoniae. Five days postchallenge, the pigs were randomized to treatment with a single IM administration of saline, a single IM administration of tulathromycin (2.5 mg/kg; day 0), or three IM administrations of enrofloxacin (5.0 mg/kg; days 0, 1, 2). Pigs were necropsied on day 12 or 13. Unchallenged controls remained healthy with no lung pathology. Compared with saline, coughing, mean lung lesion score, and proportional lung weight were significantly reduced and weight gain was significantly greater for tulathromycin-treated pigs (P < .05). Compared with enrofloxacin, there were no significant differences in proportional lung weight or weight gains, but coughing and lung lesion scores were greater for tulathromycin-treated pigs (P < .05). Tulathromycin was effective in the treatment of pneumonia following experimental infection with M. hyopneumoniae.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D004187 Disaccharides Oligosaccharides containing two monosaccharide units linked by a glycosidic bond. Disaccharide
D005260 Female Females
D006571 Heterocyclic Compounds Cyclic compounds that include atoms other than carbon in their ring structure. Heterocyclic Compound,Compound, Heterocyclic,Compounds, Heterocyclic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Jo McKelvie, and Jeremy H Morgan, and Ian A Nanjiani, and John Sherington, and Tim G Rowan, and Simon J Sunderland
March 1973, The Journal of infectious diseases,
Jo McKelvie, and Jeremy H Morgan, and Ian A Nanjiani, and John Sherington, and Tim G Rowan, and Simon J Sunderland
March 1984, American journal of veterinary research,
Jo McKelvie, and Jeremy H Morgan, and Ian A Nanjiani, and John Sherington, and Tim G Rowan, and Simon J Sunderland
December 2022, Veterinary sciences,
Jo McKelvie, and Jeremy H Morgan, and Ian A Nanjiani, and John Sherington, and Tim G Rowan, and Simon J Sunderland
July 2022, Antibiotics (Basel, Switzerland),
Jo McKelvie, and Jeremy H Morgan, and Ian A Nanjiani, and John Sherington, and Tim G Rowan, and Simon J Sunderland
January 1974, The British veterinary journal,
Jo McKelvie, and Jeremy H Morgan, and Ian A Nanjiani, and John Sherington, and Tim G Rowan, and Simon J Sunderland
August 1984, Veterinary immunology and immunopathology,
Jo McKelvie, and Jeremy H Morgan, and Ian A Nanjiani, and John Sherington, and Tim G Rowan, and Simon J Sunderland
January 1970, National Institute of Animal Health quarterly,
Jo McKelvie, and Jeremy H Morgan, and Ian A Nanjiani, and John Sherington, and Tim G Rowan, and Simon J Sunderland
December 2004, Preventive veterinary medicine,
Jo McKelvie, and Jeremy H Morgan, and Ian A Nanjiani, and John Sherington, and Tim G Rowan, and Simon J Sunderland
November 2014, Veterinary microbiology,
Jo McKelvie, and Jeremy H Morgan, and Ian A Nanjiani, and John Sherington, and Tim G Rowan, and Simon J Sunderland
June 1987, Israel journal of medical sciences,
Copied contents to your clipboard!